The death of 58-year-old nurse Susan McGowan has been linked to the weight-loss drug tirzepatide, also known as Mounjaro, shortly after she began treatment. McGowan experienced severe health issues including organ failure and pancreatitis days following her injections. Healthcare authorities underscore the drug’s benefits do outweigh risks, while robust monitoring continues. This incident marks the first suspected death associated with Mounjaro in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) emphasizes patient safety and ongoing evaluations of newly approved medications.